cas 1169630-40-3|| where to buy 18-[[(1S)-1-carboxy-4-[2-[2-[2-[2-[2-[2-(2,5-dioxopyrrolidin-1-yl)oxy-2-oxo-ethoxy]ethoxy]ethylamino]-2-oxo-ethoxy]ethoxy]ethylamino]-4-oxo-butyl]amino]-18-oxo-octadecanoic acid

Nombre del producto:18-[[(1S)-1-carboxy-4-[2-[2-[2-[2-[2-[2-(2,5-dioxopyrrolidin-1-yl)oxy-2-oxo-ethoxy]ethoxy]ethylamino]-2-oxo-ethoxy]ethoxy]ethylamino]-4-oxo-butyl]amino]-18-oxo-octadecanoic acid

IUPAC Name:17-{[(1S)-1-carboxy-3-({2-[2-({[2-(2-{2-[(2,5-dioxopyrrolidin-1-yl)oxy]-2-oxoethoxy}ethoxy)ethyl]carbamoyl}methoxy)ethoxy]ethyl}carbamoyl)propyl]carbamoyl}heptadecanoic acid

: CAS：1169630-40-3; Fórmula molecular：C39H66N4O15; Pureza：95%+

: Número de catálogo：CM457576; Peso molecular：830.97

Unidad de embalaje	Stock disponible	Precio($)
CM457576-100mg	in stock	ũƦƎƎ
CM457576-250mg	in stock	ȺƦǜũ

Consulta: sales@chemenu.com

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1169630-40-3 regularly via the above email.

Notas adicionales

Verification code*

refresh

Detalles del producto

: Núm. De CAS :1169630-40-3; Fórmula molecular:C39H66N4O15; Punto de fusión:-; Código de sonrisas:OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)ON1C(=O)CCC1=O)C(O)=O; Densidad:

: Número de catálogo:CM457576; Peso molecular:830.97; Punto de ebullición:; Nº Mdl:MFCD32704903; Almacenamiento:

Category Infos

: Fatty Acid Modified Side Chains; Fatty acid-modified side chains are small molecule modifiers and are one of the important factors that change the pharmacokinetic behavior of insulin products. Peptide drugs have the problem of short half-life and easy degradation in clinical practice. Introducing fatty acid-modified side chains into peptide drugs can increase the hydrophobicity of the drug and increase the biological half-life, thereby reducing the dosage and frequency of medication.

Formulario de consulta

Detalles del producto

Category Infos

Related Products